Joseph Aliveto
President and CEO of Milestone Pharmaceuticals
Replay available
Milestone Pharmaceuticals Inc. (MIST) Q3 2023 Earnings Call
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) Q3 2023 earnings conference call, held 2023-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. John Kam
British Heart Foundation Emeritus Professor of Clinical Cardiology, the Cardiology Clinic Academic Group, Molecular and Clinical Sciences Research Institute at St. George's University of London
Dr. Sean Picorni
Director of Arrhythmia Core Laboratory, Duke Clinical Research Institute; Assistant Professor of Medicine, Duke University School of Medicine
Dr. David Beruccia
Chief Medical Officer of Milestone Pharmaceuticals
Athena Ahn
Analyst at TD Cowen
Ted Henthoff
Analyst at Piper Sandler
Leland Gershaw
Analyst at Oppenheimer & Co.
Patrick Trucchio
Analyst at H.C. Wainwright & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Milestone Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.012 Good day, ladies and gentlemen, and welcome to the Milestone Pharmaceuticals Investor 00:00:04.012 -- 00:00:07.575 and Analyst Webcast. As a reminder, this call is being recorded. 00:00:07.575 -- 00:00:11.998 I would now like to turn the call over to Joseph Aliveto, President and CEO of Milestone 00:00:11.998 -- 00:00:15.021 Pharmaceuticals. Mr. Aliveto? 00:00:15.021 -- 00:00:19.304 Thank you, Keith. Good morning, everyone, and thank you for joining us today to review 00:00:19.304 -- 00:00:24.408 our new, recently presented, and published results from Rivera, our 00:00:24.408 -- 00:00:29.892 Phase II study evaluating atripamil and in patients with atrial fibrillation with rapid 00:00:29.892 -- 00:00:35.496 ventricular rate. As a reminder, a slide webcast accompanying today's remarks 00:00:35.496 -- 00:00:39.518 is available on our website at milestonepharma.com. 00:00:40.300 -- 00:00:45.325 During today's call, we will be making forward-looking statements, so we'll direct you 00:00:45.325 -- 00:00:50.469 to our SEC filings for a full disclosure of our risk factors. 00:00:50.469 -- 00:00:56.771 For today's call, We are honored to be joined by two leading cardiac electrophysiologists 00:00:56.771 -- 00:01:01.214 and atrial fibrillation experts. And I'd like to welcome Dr. 00:01:01.214 -- 00:01:06.318 John Kam, British Heart Foundation Emeritus Professor of Clinical 00:01:06.318 -- 00:01:11.581 Cardiology, the Cardiology Clinic Academic Group, Molecular and Clinical 00:01:11.581 -- 00:01:17.145 Sciences Research Institute at St. George's University of London. 00:01:17.145 -- 00:01:22.295 And Dr. Sean Picorni, Director of Arrhythmia Core Laboratory, 00:01:22.295 -- 00:01:27.257 Duke Clinical Research Institute, and Assistant Professor ...